Urinary Incontinence
Conditions
Keywords
Urinary Incontinence, Dementia, Randomised Cross Over Trial, continence products
Brief summary
Urinary incontinence is a common health problem that significantly affects the quality of life of older people. The risk of urinary incontinence is increased in people living with dementia. Many products aid the management of urinary incontinence, with many people choosing to manage incontinence with containment products. The purpose of this study is to examine and compare two containment products - pull ups and style briefs with tapes, in self-management of urinary incontinence in people living with dementia.
Detailed description
Urinary incontinence is common in later life and the risk of incontinence is increased in people living with dementia (PLWD). For many, incontinence is managed with toileting assistance containment products, regardless of other potential treatments. As toileting becomes more difficult and incontinence more likely, a containment product which mimics normal underwear, which is familiar to the PLWD may be an attractive option to preserve successful toileting and self management of continence with containment products and toileting for as long as possible. This study is designed to explore the relative benefits or disadvantages of containment with either briefs with tapes or pull ups in the self management of continence by containment products and toileting in PLWD. Primary objective To examine the benefits and disadvantages of self-management of urinary incontinence by pulls compared to style briefs with tapes in PLWD. Research Method/Procedures This study will comprise a three-phase design A small sample, exploratory study to ascertain the feasibility of recruitment, trial design and conduct and to enable calculation of an effect size for the trial primary outcome including care partner interviews and exploration of qualitative factors in use not captured elsewhere, economic variables and costs. A crossover study with an interval washout (pre-trial care) period. Each participant will undergo a 3-day assessment of incontinence severity to ensure eligibility and then, in random order, a four-week period of use of one investigational product, a two week return to their usual care (the care methods undertaken prior to trial commencement) and then a four-week period of use of the comparative investigational product. A post-treatment phase, qualitative semi-structured interview with PLWD and their care partners to discuss the impressions of the use of each investigational product.
Interventions
DEVICEPull Ups
Participants will be asked to wear pull-ups continence products for the duration of four weeks
DEVICEStyled Briefs with tapes
Participants will be asked to wear styled briefs with tapes for the duration of four weeks
Sponsors
Essity Hygiene and Health AB
University of Alberta
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE
Intervention model description
Crossover trial of briefs with tapes versus pull ups for the containment of urinary incontinence
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Able to toilet independently or independently following prompting or instruction to do so. * Independently mobile, with or without walking aids * Use of any type of continence produce, for the management of moderate incontinence. * Moderate incontinence severity as measured by Incontinence Severity (Sandvik) index. * Availability of care partner willing to co-operate and participate in trail procedures
Exclusion criteria
* Need for daily help with dexterity to apply any continence product * Waist size or body shape which renders any size of either investigational product inapplicable * PLWD unable to indicate the need to toilet * PLWD with significant faecal incontinence * Permanent residence in nursing home or expected to enter nursing home within two months of trail entry * Presence of any other condition, which, in the opinion of the investigator makes PLWD unable to participate in the necessary trail procedures.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Successful Toileting Episodes | 56 days | Between group change in the proportion of successful toileting episodes, defined as episodes of independent toileting with pad use and reapplication without leakage, misapplication or failure, between baseline measurement and end of study investigational product. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of unintentional leakage | 56 days | Number of unintentionally leaking products due to misapplication, average per 24h over the duration of the study |
| Number of episodes leading to unintentionally soiled or wet clothing | 56 days | Difference in number of episodes leading to wet or unintentionally soiled clothing, between investigational products over the duration of the study. |
| Number of laundry episodes | 56 days | Differences in number of laundry episodes(either clothes or bed linen) between investigational products over the duration of the study |
| Number of hours of care partner time | 56 days | Difference in care partner time in maintaining continence with investigational products and toileting over the duration of the study |
| Number of continence products used | 56 days | Number of products used in excess of those deemed necessary \[2/24h\] according to degree of incontinence. |
| Quality of life at baseline and end of study | 56 days | Change in quality of life measures between baseline assessment and end of study using Quality of Life Alzheimer Disease (ADQoL) validated questionnaire. The ADQoL scores can be calculated based on patient and caregiver reports and can be combined into a single score, with total scores range from 13 to 52, with higher scores indicating better QoL |
| Zarit burden index | 56 days | Comparison of change in Zarit burden index between baseline and end of investigational product use compared between products. Zarit burden index consists of 22 items used to calculate a total score that can range between 0 and 88 (88 = more burden) |
| Number of Care Partners satisfied with treatment | 56 days | Persons living with dementia and care partner assessment of satisfaction with each investigational product and its use, assessed at the end of each testing period |
| Number of PLWD satisfied with treatment | 56 days | Impressions of ease of use and user satisfaction on the part of persons living with dementia and care partner, at the end of each period of investigational product use, assessed by semi-structured interview |
| Cost of care partner time | 56 days | Difference in care partner cost (costed at minimum wage per hour) in maintaining continence with investigational products and toileting over the duration of the study |
Countries
Canada
Outcome results
None listed